Dolby Laboratories (NYSE:DLB) SVP Sells $164,700.00 in Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $54.90, for a total transaction of $164,700.00. Following the completion of the transaction, the senior vice president owned 80,603 shares of the company’s stock, valued at $4,425,104.70. This trade represents a 3.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Dolby Laboratories Stock Down 0.2%

DLB opened at $54.03 on Friday. The business’s fifty day simple moving average is $60.22 and its 200 day simple moving average is $63.42. Dolby Laboratories has a 52 week low of $52.45 and a 52 week high of $77.00. The stock has a market cap of $5.11 billion, a PE ratio of 21.36 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, equities analysts anticipate that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.7%. Dolby Laboratories’s dividend payout ratio is currently 56.92%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a report on Monday, April 27th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Finally, Rosenblatt Securities reissued a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Institutional Investors Weigh In On Dolby Laboratories

Several institutional investors and hedge funds have recently bought and sold shares of the business. First Horizon Corp purchased a new position in shares of Dolby Laboratories during the third quarter valued at approximately $25,000. Hantz Financial Services Inc. lifted its stake in Dolby Laboratories by 166.7% in the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock worth $25,000 after acquiring an additional 220 shares during the period. Rothschild Investment LLC boosted its holdings in Dolby Laboratories by 4,046.7% in the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after acquiring an additional 607 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in Dolby Laboratories in the third quarter valued at $50,000. Finally, Optiver Holding B.V. increased its position in Dolby Laboratories by 7,955.6% during the 3rd quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock valued at $52,000 after purchasing an additional 716 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.